By jayanne global business editorial committee
“No Data, No Market.”
That principle is increasingly becoming the baseline for entering the European cosmetics market. As highly functional ingredients such as stem cells, exosomes, and regenerative compounds continue to emerge, regulatory scrutiny is intensifying. Simple irritation testing alone is no longer sufficient to support efficacy claims in Europe and the United States.
Against this backdrop, Germany-based biotechnology laboratory Makrolife Biotech is proposing a different approach to cosmetic efficacy verification — one centered around immune response analysis using living human immune cells and AI-driven biological interpretation. Beauty Science Magazine spoke with CEO Fähzan Ahmad about cosmetic immunology, cell-based efficacy testing, and the future of scientific substantiation in beauty.
